Structural Characterization of the Avidin Interactions with Fluorescent Pyrene-Conjugates: 1-Biotinylpyrene and 1-Desthiobiotinylpyrene.
Avidin is a tetrameric protein that belongs to the calycin superfamily. It has been studied mainly because of its extraordinary affinity to biotin, which led to a wide range of applications based on the avidin-biotin system. In the present study, we report the first crystal structures of avidin in a complex with two novel fluorescent pyrene derivatives: 1-biotinylpyrene (B9P) and 1-desthiobiotinylpyrene (D9P). The crystal structures were solved by molecular replacement using the coordinates of avidin molecule as a starting model and the final models of avidin/B9P and avidin/D9P were refined to resolutions of 2.0 Å and 2.1 Å, respectively. Our data reveal changes in loop conformation as well as in overall fold and quaternary arrangement of the avidin upon the binding of these fluorescent probes. Moreover, the crystal structures allowed analysis of the details of the interactions between the protein and the pyrene derivatives. Structural description of the complexes will contribute to the design of conjugates for expanding the capabilities of avidin-biotin technology.
Institute of Technical Biochemistry, Faculty of Biotechnology and Food Sciences, Lodz University of Technology, 90-924 Łódź, Stefanowskiego 4/10, Poland. pavol.strzelczyk@gmail.com.
Paweł
P
Strzelczyk
Department of Organic Chemistry, Faculty of Chemistry, University of Lodz, 91-403 Łódź, Tamka 12, Poland. damplaz@uni.lodz.pl.
Damian
D
Plażuk
Department of Organic Chemistry, Faculty of Chemistry, University of Lodz, 91-403 Łódź, Tamka 12, Poland. janzak@uni.lodz.pl.
Janusz
J
Zakrzewski
Institute of Technical Biochemistry, Faculty of Biotechnology and Food Sciences, Lodz University of Technology, 90-924 Łódź, Stefanowskiego 4/10, Poland. grzegorz.bujacz@p.lodz.pl.
Grzegorz
G
Bujacz
1-biotinylpyrene; 1-desthiobiotinylpyrene; avidin; biotin; crystal structure; protein crystallography; protein-ligand interaction; pyrene
Acta Crystallogr D Biol Crystallogr. 2001 Oct;57(Pt 10):1451-6
11567159
Anal Chem. 2002 Mar 1;74(5):1149-56
11924977
Bioorg Med Chem Lett. 2003 Jul 7;13(13):2127-30
12798319
Acta Crystallogr D Biol Crystallogr. 2004 Dec;60(Pt 12 Pt 1):2126-32
15572765
Acta Crystallogr D Biol Crystallogr. 2004 Dec;60(Pt 12 Pt 1):2184-95
15572771
Angew Chem Int Ed Engl. 2005 Dec 2;44(47):7764-7
16276543
Org Lett. 2006 Apr 27;8(9):1883-6
16623575
Cell Mol Life Sci. 2006 Dec;63(24):2992-3017
17086379
Cancer Res. 2007 Mar 15;67(6):2791-9
17363601
J Mol Biol. 2007 Sep 21;372(3):774-97
17681537
Adv Drug Deliv Rev. 2008 Jun 30;60(10):1167-76
18479776
Proteomics. 2008 Oct;8(19):4012-24
18763706
J Comput Chem. 2010 Jan 15;31(1):133-43
19421996
Target Oncol. 2009 Sep;4(3):201-17
19838639
Methods Enzymol. 2009;464:147-66
19903554
Acta Crystallogr D Biol Crystallogr. 2010 Feb;66(Pt 2):133-44
20124693
Acta Crystallogr D Biol Crystallogr. 2010 Apr;66(Pt 4):486-501
20383002
Chem Commun (Camb). 2010 Aug 14;46(30):5575-7
20467665
Org Biomol Chem. 2011 Jan 21;9(2):408-17
20967359
Acta Crystallogr D Biol Crystallogr. 2011 Apr;67(Pt 4):235-42
21460441
Methods Enzymol. 1990;184:5-13
2201884
Chem Biol. 2011 Oct 28;18(10):1261-72
22035795
Nanoscale. 2012 Nov 21;4(22):7097-105
23069779
J Am Chem Soc. 2013 Mar 20;135(11):4567-72
23461361
Chem Biol Interact. 2013 Jun 25;204(1):6-12
23603015
Adv Protein Chem. 1975;29:85-133
237414
Chem Commun (Camb). 2014 May 25;50(40):5336-8
24185552
Protein Eng. 1995 Feb;8(2):127-34
7630882
FEBS Lett. 1993 Oct 25;333(1-2):99-102
8224179
J Mol Biol. 1994 Jan 7;235(1):42-6
8289264
Proc Natl Acad Sci U S A. 1993 Jun 1;90(11):5076-80
8506353